U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1651G>A (p.Gly551Ser) AND CFTR-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 28, 2017
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001831533.2

Allele description [Variation Report for NM_000492.4(CFTR):c.1651G>A (p.Gly551Ser)]

NM_000492.4(CFTR):c.1651G>A (p.Gly551Ser)

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
LOC111674475:CFTR intron 11 enhancer [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1651G>A (p.Gly551Ser)
HGVS:
  • NC_000007.14:g.117587805G>A
  • NG_016465.4:g.127022G>A
  • NG_056131.3:g.760G>A
  • NM_000492.4:c.1651G>AMANE SELECT
  • NP_000483.3:p.Gly551Ser
  • NP_000483.3:p.Gly551Ser
  • LRG_663t1:c.1651G>A
  • LRG_663:g.127022G>A
  • LRG_663p1:p.Gly551Ser
  • NC_000007.13:g.117227859G>A
  • NG_056131.1:g.129G>A
  • NM_000492.3:c.1651G>A
  • P13569:p.Gly551Ser
Protein change:
G551S; GLY551SER
Links:
PharmGKB: 1183960780; PharmGKB: 1183960780PA165950341; PharmGKB Clinical Annotation: 1183960780; UniProtKB: P13569#VAR_000180; OMIM: 602421.0037; dbSNP: rs121909013
NCBI 1000 Genomes Browser:
rs121909013
Molecular consequence:
  • NM_000492.4:c.1651G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
CFTR-related disorder (CFTR-RD)
Synonyms:
CFTR-related disorders; CFTR-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002080635Natera, Inc.
no assertion criteria provided
Pathogenic
(Aug 28, 2017)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002080635.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024